Anda Litigation

Strategies and Tactics for Pharmaceutical Patent Litigators

Kenneth L. Dorsney (Autor)

Media-Kombination

840 Seiten

2014
American Bar Association
9781614384786 (ISBN)

Titel ist leider vergriffen;
keine Neuauflage

Artikel merken

Examining the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and U.S. patent law in the context of Paragraph IV ANDA litigation, ANDA Litigation focuses both on the current and developing law as well as the strategies and tactics employed by the litigants. This is a ready roadmap to practice in the area - an especially valuable resource as the Hatch-Waxman Act with it amendments is a hybrid of two already complex areas of the law-U. S. patent law and FDA regulatory law-makes patent litigation in this area especially complicated and hotly contested. It begins with an explanation of the act, its implementation, and litigation under the act, including responses to the complaint, discovery, the work of experts, and patent claim construction and summary judgment. Additional practice-focused information examines issues such as preparing the case for trial, the work of trial, managing the litigation process, post-trial issues and appeals, remedies, settlement, antitrust implications, and regulation and litigation of pharmaceuticals outside the U.S.

Kenneth Dorsney, a registered patent attorney, maintains an active practice representing corporate clients and the interests of outside counsel in a wide variety of complex commercial matters, including patent, trademark, trade secret, and copyright litigation, mediation, and dispute resolution in the District of Delaware.

Erscheint lt. Verlag	7.8.2014
Verlagsort	Chicago, IL
Sprache	englisch
Maße	189 x 263 mm
Gewicht	1670 g
Themenwelt	Recht / Steuern ► EU / Internationales Recht
	Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Zivilverfahrensrecht
	Recht / Steuern ► Wirtschaftsrecht ► Urheberrecht
ISBN-13	9781614384786 / 9781614384786
Zustand	Neuware